Early exploration of COVID-19 vaccination safety and effectiveness during pregnancy: interim descriptive data from a prospective observational study

OBJECTIVE: During December 2020, a massive vaccination program was introduced in our country. The Pfizer-BioNTech, BNT162b2 vaccine was first offered exclusively to high-risk population, such as medical personnel (including pregnant women). In this study we compare short term outcomes in vaccinated...

Descripción completa

Detalles Bibliográficos
Autores principales: Bleicher, Inna, Kadour-Peero, Einav, Sagi-Dain, Lena, Sagi, Shlomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463327/
https://www.ncbi.nlm.nih.gov/pubmed/34600749
http://dx.doi.org/10.1016/j.vaccine.2021.09.043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463327/
https://www.ncbi.nlm.nih.gov/pubmed/34600749
http://dx.doi.org/10.1016/j.vaccine.2021.09.043

Ejemplares similares